Estee Lauder Companies IncEstée Lauder beat EPS expectations and raised full-year EPS guidance.
The nine personal care stocks tracked by the report delivered a strong first quarter, with aggregate revenues beating analysts' consensus estimates by 2.5% while next quarter's revenue guidance came in 3.5% below expectations. Edgewell Personal Care reported flat revenues of $519.5 million, in line with estimates, and posted a very strong quarter with beats on EBITDA and organic revenue. USANA Health Sciences was the best performer, with revenues of $250.2 million exceeding expectations by 3.8% and solid beats on EBITDA and EPS. Herbalife was the weakest, with revenues of $1.32 billion up 7.8% year on year but next quarter EBITDA guidance missing estimates. Medifast reported revenues of $76.04 million, down 34.3% year on year, yet beat expectations by 9.9% and raised full-year guidance. Estée Lauder posted revenues of $3.71 billion, up 4.6% year on year, in line with estimates, and exceeded EPS expectations while raising full-year EPS guidance. Share prices of the group have risen 11.7% on average since the latest earnings results.
Estee Lauder Companies IncEstée Lauder beat EPS expectations and raised full-year EPS guidance.
Edgewell Personal Care CoEdgewell Personal Care beat EBITDA and organic revenue estimates.
Herbalife Nutrition LtdHerbalife's next quarter EBITDA guidance missed estimates.
MEDIFAST INCMedifast beat revenue expectations by 9.9% and raised full-year guidance.
USANA Health Sciences IncUSANA Health Sciences beat revenue expectations by 3.8% and had solid EBITDA and EPS beats.